Ling Xu

1.6k total citations
54 papers, 1.1k citations indexed

About

Ling Xu is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ling Xu has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Physiology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ling Xu's work include Advanced Glycation End Products research (5 papers), DNA Repair Mechanisms (3 papers) and CRISPR and Genetic Engineering (3 papers). Ling Xu is often cited by papers focused on Advanced Glycation End Products research (5 papers), DNA Repair Mechanisms (3 papers) and CRISPR and Genetic Engineering (3 papers). Ling Xu collaborates with scholars based in China, United States and Canada. Ling Xu's co-authors include Mei Cheng, Baoying Li, Xianhua Li, Virginia L. Brooks, Haiqing Gao, Alan F. Sved, Ruben C. Petreaca, Constance I. Nugent, Hongyi Qi and Yang Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Cell Biology.

In The Last Decade

Ling Xu

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Xu China 21 383 183 155 146 118 54 1.1k
Stefania Gorini Italy 20 423 1.1× 281 1.5× 143 0.9× 202 1.4× 167 1.4× 50 1.3k
Liang Wu China 23 600 1.6× 131 0.7× 126 0.8× 144 1.0× 69 0.6× 63 1.5k
Shihong Chen China 19 650 1.7× 253 1.4× 180 1.2× 56 0.4× 79 0.7× 70 1.2k
Yuan Zhao China 22 465 1.2× 96 0.5× 64 0.4× 100 0.7× 74 0.6× 72 1.3k
Huan Chen China 15 349 0.9× 113 0.6× 141 0.9× 103 0.7× 124 1.1× 55 1.3k
Elisabetta Cavalieri Italy 20 423 1.1× 165 0.9× 74 0.5× 64 0.4× 174 1.5× 29 1.6k
Feng‐Ming Ho Taiwan 25 699 1.8× 214 1.2× 65 0.4× 93 0.6× 148 1.3× 39 1.8k
Roy B. Dyer United States 21 823 2.1× 239 1.3× 87 0.6× 118 0.8× 95 0.8× 46 1.7k
Junhao Liu China 20 448 1.2× 232 1.3× 152 1.0× 42 0.3× 63 0.5× 92 1.1k
Theresa Chen United States 25 505 1.3× 193 1.1× 309 2.0× 127 0.9× 71 0.6× 38 1.7k

Countries citing papers authored by Ling Xu

Since Specialization
Citations

This map shows the geographic impact of Ling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xu more than expected).

Fields of papers citing papers by Ling Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xu. The network helps show where Ling Xu may publish in the future.

Co-authorship network of co-authors of Ling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xu. A scholar is included among the top collaborators of Ling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xu. Ling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Lixia, Hui Chen, Hui Li, et al.. (2025). Lipidomic Analysis of Serum Lipid Profiles in Idiopathic Central Precocious Puberty and the Potential Regulatory Role of GnRHa in Lipid Metabolism. Biomedical Chromatography. 39(4). e70029–e70029.
2.
Thomas, Joshua D., Mao Yin, Natalya D. Bodyak, et al.. (2024). Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 23(4). 541–551.
3.
Zhang, Qinghui, et al.. (2023). A comprehensive review of the relationship between autophagy and sorafenib-resistance in hepatocellular carcinoma: ferroptosis is noteworthy. Frontiers in Cell and Developmental Biology. 11. 1156383–1156383. 18 indexed citations
5.
Wang, Zhe, Lin Mu, Feng He, et al.. (2022). Expression patterns of platinum resistance-related genes in lung adenocarcinoma and related clinical value models. Frontiers in Genetics. 13. 993322–993322. 3 indexed citations
6.
Qiu, Yu, Yueyang Zhao, Zhimin Long, et al.. (2021). Liquiritigenin promotes osteogenic differentiation and prevents bone loss via inducing auto-lysosomal degradation and inhibiting apoptosis. Genes & Diseases. 10(1). 284–300. 7 indexed citations
9.
Xue, Qiang, Yang Liu, Hongyi Qi, et al.. (2013). A Novel Brain Neurovascular Unit Model with Neurons, Astrocytes and Microvascular Endothelial Cells of Rat. International Journal of Biological Sciences. 9(2). 174–189. 117 indexed citations
10.
Wang, Ben, Wenke Wang, Weibo Niu, et al.. (2013). SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6. Carcinogenesis. 35(2). 282–291. 60 indexed citations
11.
Xu, Ling. (2012). Effect of cyclophosphamide combined with cyclosporine A on the prognosis of acute paraquat poisoning. Central Plains Medical Journal. 39(11). 44–46. 1 indexed citations
12.
Xu, Ling, et al.. (2012). EXPRESSION OF THE SOX2 GENE IN DIFFERENT TISSUES AND DIFFERENT MONTHS ON TESTIS OF HYRIOPSIS SCHLEGELII. Acta Hydrobiologica Sinica. 36(2). 205–211. 3 indexed citations
13.
Wang, Lin, et al.. (2011). Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma. Oncology Letters. 2(4). 707–712. 5 indexed citations
14.
Walsh, Shawn P., Changyou Zhou, Jiafang He, et al.. (2011). 3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3390–3394. 20 indexed citations
15.
Cheng, Mei, et al.. (2007). Cardioprotective Effects of Grape Seed Proanthocyanidins Extracts in Streptozocin Induced Diabetic Rats. Journal of Cardiovascular Pharmacology. 50(5). 503–509. 72 indexed citations
16.
Petreaca, Ruben C., et al.. (2006). Chromosome end protection plasticity revealed by Stn1p and Ten1p bypass of Cdc13p. Nature Cell Biology. 8(7). 748–755. 60 indexed citations
17.
Xu, Ling, Jianli Liu, Jingfang Lin, et al.. (2003). Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population. Open Repository and Bibliography (University of Liège). 1 indexed citations
18.
Paredes, N., Ling Xu, Leslie R. Berry, & Anthony K.C. Chan. (2003). The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces. British Journal of Haematology. 120(2). 315–324. 23 indexed citations
19.
Chan, Anthony K.C., Leslie R. Berry, Jun Li, et al.. (2003). Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity. Journal of Biological Chemistry. 278(19). 17438–17447. 48 indexed citations
20.
Streif, Werner, Bosco Paes, Leslie R. Berry, et al.. (2000). Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates. Blood Coagulation & Fibrinolysis. 11. S133–S134. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026